IDERA PHARMACEUTICAL IDRA (NASDAQ)

Among the earnings stories for Monday, Aug. 4, from AP Financial News: BISMARCK, N.D. (AP)--Energy and construction company MDU Resources Group Inc. said Monday its second-quarter ...READ MORE

(CAMBRIDGE, Mass.)Idera Pharmaceuticals Inc. on Monday reported a profit for the fiscal second quarter, beating Wall Street's expectations for a loss. The developer of experimental biotechnology tre...READ MORE

(NEW YORK)More than 50 companies in the health care sector were added to the Russell 2000 in this year's reconstitution of the small stock index, while 30 companies in the sector were re...READ MORE

(NEW YORK)Shares of Vertex Pharmaceuticals Inc. rose sharply Wednesday after a Lazard Capital Markets analyst removed his "Sell" rating on the stock, saying a pullback in share price somewha...READ MORE

(CAMBRIDGE, Mass.)Biotechnology company Idera Pharmaceuticals Inc. said Wednesday it passed a regulatory antitrust review and will move ahead on a licensing deal with Germany's Merck KGaA.READ MORE

(CAMBRIDGE, Mass.)Drug developer Idera Pharmaceuticals Inc. said Wednesday its president, Dr. Robert W. Karr, will resign Monday. Karr will remain a member of the board of directors and signed a con...READ MORE

(CAMBRIDGE, Mass.)Drug developer Idera Pharmaceuticals Inc. said Wednesday it is teaming up with Germany's Merck KGaA to develop and sell cancer treatments. The licensing deal includes only cancer t...READ MORE